Kunio Matsuoka

Title: Kunio Matsuoka: Innovator in Transgenic Research

Introduction

Kunio Matsuoka is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of transgenic research, particularly in the development of animal models for various diseases. His work has implications for understanding and treating a range of health conditions.

Latest Patents

Matsuoka holds a patent for the invention titled "25-hydroxyvitamin D3 24-hydroylase transgenic rats." This transgenic animal model can be utilized for studying renal disease, bone disease, joint disease, pulmonary disease, hyperlipidemia, arteriosclerosis, cardiac disease, diabetes, obesity, digestive organ disease, infectious disease, allergic disease, endocrine disease, dementia, or cancer, along with their complications. The invention provides a nonhuman transgenic mammal that aids in unraveling the mechanisms of these diseases, exploring therapeutic modalities, and screening candidate therapeutic drugs.

Career Highlights

Kunio Matsuoka is affiliated with Takeda Chemical Industries, Inc., where he continues to advance his research. His work has garnered attention for its potential to impact medical science and therapeutic development.

Collaborations

Matsuoka has collaborated with notable colleagues, including Hisao Kasuga and Masami Isaka. These partnerships have contributed to the advancement of research in transgenic models and their applications in medicine.

Conclusion

Kunio Matsuoka's innovative work in transgenic research exemplifies the potential of scientific advancements to address complex health issues. His contributions continue to pave the way for future discoveries in the field.